Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.
Early lab-based tests with human cells have shown the molecule’s ability to completely block multiple strains of cold virus, and the team hope to move to animal and then human trials. The results of initial tests are published today in the journal Nature Chemistry.
A drug like this could be extremely beneficial if given early in infection, and we are working on making a version that could be inhaled, so that it gets to the lungs quickly.Professor Ed Tate
The common cold is caused by a family of viruses with hundreds of variants, making it nearly impossible to become immune to or vaccinate against all of them. On top of that, the viruses evolve rapidly, meaning they can quickly gain resistance to drugs.
For these reasons, most cold remedies rely on treating the symptoms of the infection – such as runny nose, sore throat and fever – rather than tackling the virus itself.
However a new molecule, developed by researchers at Imperial College London, targets N-myristoyltransferase (NMT), a protein in human cells. Viruses ‘hijack’ NMT from human cells to construct the protein ‘shell’, or capsid, which protects the virus genome.
All strains of the virus need this same human protein to make new copies of themselves, so the molecule should work against all of them. Additionally, the molecule also works against viruses related to the cold virus, such as polio and foot and mouth disease viruses.
More than just an inconvenience
The molecule targets a human protein and not the virus itself, making emergence of resistant viruses highly unlikely.
Lead researcher Professor Ed Tate, from the Department of Chemistry at Imperial, said: “The common cold is an inconvenience for most of us, but can cause serious complications in people with conditions like asthma and COPD.
“A drug like this could be extremely beneficial if given early in infection, and we are working on making a version that could be inhaled, so that it gets to the lungs quickly.”
There have been previous attempts to create drugs that target human cells rather than the viruses, but many have the side effect of being toxic. The researchers showed that the new molecule completely blocked several strains of the virus without affecting human cells. Further study is needed to make sure it is not toxic in the body.
The common cold, via malaria and Viagra
The research team included the labs of Professor Roberto Solari and Professor Seb Johnston at Imperial’s National Heart & Lung Institute, Dr Aurelie Mousnier from Imperial and Queen’s University Belfast, structural biologists at the University of York, and colleagues at the Pirbright Institute.
Professor Tate said: “The way the drug works means that we would need to be sure it was being used against the cold virus, and not similar conditions with different causes, to minimise the chance of toxic side effects.”
The medicinal chemistry team in the Tate group at Imperial, led by Dr Andy Bell (who previously invented Viagra as a researcher at Pfizer), were originally looking for compounds that targeted the protein in malaria parasites. Screening large libraries of compounds, they found two hits and were surprised to discover that they worked best together.
By inventing a novel way to combine the two, they created a molecule, codenamed IMP-1088, which is more than a hundred times more potent than previous molecules targeting the protein in humans.
The Latest on: Common cold
[google_news title=”” keyword=”common cold” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Common cold
- If Your Cold Lingers, Here Are 13 Things It Could Meanon March 1, 2024 at 6:31 am
Adults can expect to get two to three colds each year with children experiencing even more, according to the Centers for Disease Control and Prevention (CDC)—colds are the number one reason adults ...
- Cold Or Flu? Learn How To Sleep When You’re Sick With These Expert Tipson February 29, 2024 at 8:16 am
Being sick is miserable enough, but even worse when you can't manage to fall asleep (and stay asleep). Here's how to sleep when you're sick, according to experts.
- Seasonal allergies or the common cold: Pollen levels increase as spring approacheson February 26, 2024 at 6:43 pm
Allergy season is coming, or possibly, already here. With flowers blooming and bees returning, many people are seeking out allergy medication to overcome the pollen. But as Dr. Austin Sherman explains ...
- Medicine: Cold Vaccine? Noon February 26, 2024 at 4:00 pm
A score of the nation’s top virus researchers put their heads together in Manhattan last week and collectively bemoaned the fact that they still can offer no preventive and no cure for the commonest ...
- ‘Kind and beautiful’ woman, 34, died just weeks after feeling tired and thinking she had a common coldon February 26, 2024 at 6:27 am
A “KIND and beautiful” woman died from a rare disorder just weeks after a suspected cold. Alicia Whelan, 34, took herself to A&E after weeks of feeling tired. She expected to leave ...
- Wait, Is It Normal to Get a Cold Every Month?on February 24, 2024 at 9:25 am
Getting sick is never fun and if you routinely feel under the weather, it can feel like you just can’t catch a break. The common cold is an illness affecting the nose and throat. While its impacts on ...
- Echinacea Not Effective for the Common Coldon February 23, 2024 at 4:00 pm
The herbal remedy echinacea is a popular but unproven treatment for the common cold. In this trial from the University of Virginia, researchers examined the effects of three different extracts of ...
- Four more surprising facts about the common coldon February 21, 2024 at 4:00 pm
There is far more to the common cold than meets the eye. While most of us are over familiar with the flu-like symptoms, there's plenty we don't know about this common condition. Here, we look at ...
- Medicine: The Common Coldon February 16, 2024 at 9:50 pm
Ward is a persistent man. Virology expert at Johns HopkinsUniversity, he has spent the better part of the past three yearslooking for a cure for the common cold. In Chicago last week, at ...
via Bing News